FDA Grants AP Status for Metformin Hydrochloride ANDA075972
The FDA has granted an Abbreviated Approval (AP) status for ANDA075972, a generic formulation of Metformin Hydrochloride submitted by Chartwell.
Therapeutic Area
Therapeutic area intelligence for Oral Hypoglycemic with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.